Shopping Cart
- Remove All
Your shopping cart is currently empty
Ro3280 (Ro5203280) is an effective, specific inhibitor of PLK1(IC50=3, Kd=0.09 nM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $54 | In Stock | |
| 5 mg | $118 | In Stock | |
| 10 mg | $198 | In Stock | |
| 25 mg | $431 | In Stock | |
| 50 mg | $638 | In Stock | |
| 100 mg | $889 | In Stock | |
| 200 mg | $1,220 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $143 | In Stock |
| Description | Ro3280 (Ro5203280) is an effective, specific inhibitor of PLK1(IC50=3, Kd=0.09 nM). |
| Targets&IC50 | RPS6KA6 (KinDom.2):560 nM (Kd), DAPK3:70 nM (Kd), CAMKK2:87 nM (Kd), FER:53 nM (Kd), CAMKK1:1100 nM (Kd), TTK:51 nM (Kd), PTK2B (Protein Tyrosine Kinase 2B):130 nM (Kd), PLK1:3 nM, GAK:87 nM (Kd), ALK:230 nM (Kd), PTK2 (Protein Tyrosine Kinase 2):84 nM (Kd), MYLK:170 nM (Kd), DAPK1:100 nM (Kd) |
| In vitro | In nude mice implanted with HT-29 human colon tumors, RO3280 (40 mg/kg) was effective in inhibiting tumor cell proliferation. |
| In vivo | RO3280 exhibits antitumor activity across a variety of tumor cell lines, effectively inhibiting cancer cell proliferation. Specifically, it demonstrates potency against lung cancer cell line H82 (IC50=5 nM), colorectal cancer cell HT-29 (IC50=10 nM), breast cancer cell MDA-MB-468 (IC50=19 nM), prostate cancer cell PC3 (IC50=12 nM), and skin cancer cell A375 (IC50=70 nM). |
| Synonyms | Ro5203280, RO 3280 |
| Molecular Weight | 543.61 |
| Formula | C27H35F2N7O3 |
| Cas No. | 1062243-51-9 |
| Smiles | COc1cc(ccc1Nc1ncc2N(C)C(=O)C(F)(F)CN(C3CCCC3)c2n1)C(=O)NC1CCN(C)CC1 |
| Relative Density. | no data available |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 27.2 mg/mL (50.04 mM), Sonication is recommended. Ethanol: 27.2 mg/mL (50.04 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.68 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO/Ethanol
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.